Skip to main content

Table 1 Patient’s characteristics of study population

From: Detection of endocrine disorders in young children with multi-transfused thalassemia major

Characteristics Summary statistics
Total 120 patients
Male 66 (55%) Female 54 (45%)
Age / years
 Mean (SD) 11.34 (2.27) 11.12 (2.01)
 Median (range) 11.4 (2–12) 11.6 (2–12)
Duration of disease/years
 Mean (SD) 5.74 (3.45) 5.14 (3.20)
 Weight (Kg) Mean (SD) 28 (7.65) 25 (6.67)
 Height (Cm) Mean (SD) 129 (19.54) 124 (18.35)
Body mass index (BMI) kg/m2
 Mean (SD) 16.82 (8.73) 16.26 (6.78)
 Median (range) 16.5 (14–28) 16.9 (15–29)
 Malnutrition according to Z score for BMI (percentage) 44 (66.67%) 40 (74.07%)
Family history of thalassemia major
 No 26 (39.39%) 20 (37.04%)
 Yes 40 (60.61%) 34 (62.96%)
Family history of endocrine disorders
 No 41 (62.12%) 32 (59.26%)
 Yes 25 (37.88%) 22 (40.74%)
Ferritin level
 Mean (SD) 3121 (1390) 2997 (1480)
 Median (range) 2653 (58–6550) 2342 (47–6520)
Hemoglobin level before transfusion (Gram/DL)
 Mean (SD) 6.82 (1.45) 6.65 (1.89)
 Median (range) 7.5 (2.8–11) 7.2 (2.5–11)
Splenectomy
 No 30 (45.45%) 35 (64.81%)
 Yes 36(54.55%) 19 (35.19%)
Deferasirox (N. of patients) 20 (30.30%) 16 (29.63%)
Desferoxamine (N. of patients) 14 (21.22%) 11 (20.37%)
Combined therapy (N. of patients) 32 (48.48%) 27 (50%)